908 Devices Inc. (MASS)
NASDAQ: MASS · Real-Time Price · USD
5.57
-0.15 (-2.62%)
At close: Sep 12, 2025, 4:00 PM EDT
5.60
+0.03 (0.54%)
After-hours: Sep 12, 2025, 4:57 PM EDT
908 Devices Market Cap
908 Devices has a market cap or net worth of $202.08 million as of September 12, 2025. Its market cap has increased by 43.97% in one year.
Market Cap
202.08M
Enterprise Value
87.93M
1-Year Change
43.97%
Ranking
Category
Stock Price
$5.57
Market Cap Chart
Since December 18, 2020, 908 Devices's market cap has decreased from $1.28B to $202.08M, a decrease of -84.26%. That is a compound annual growth rate of -32.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 202.08M | 163.78% |
| Dec 31, 2024 | 76.61M | -78.91% |
| Dec 29, 2023 | 363.29M | 50.35% |
| Dec 30, 2022 | 241.64M | -69.92% |
| Dec 31, 2021 | 803.26M | -46.17% |
| Dec 31, 2020 | 1.49B | 16.22% |
| Dec 18, 2020 | 1.28B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.45B |
| Johnson & Johnson | 423.36B |
| AbbVie | 373.87B |
| UnitedHealth Group | 314.07B |
| AstraZeneca | 250.26B |
| Novo Nordisk | 244.96B |
| Novartis AG | 244.56B |
| Abbott Laboratories | 225.15B |